09:16 AM EDT, 09/16/2024 (MT Newswires) -- Bausch + Lomb ( BLCO ) is exploring a potential sale as it navigates a complex separation from its debt-laden parent company, Bausch Health, Financial Times reported Monday, citing unnamed people familiar with the matter.

The eye care business, valued at over $10 billion including debt, is working with Goldman Sachs to gauge interest from private equity buyers, the report said.

The sale process could lead to a significant premium, but no deal is guaranteed, the sources reportedly told Financial Times.

Bausch + Lomb ( BLCO ) did not immediately respond to MT Newswires' request for comment.

Shares of the company jumped more than 15% in recent Monday premarket activity.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 17.98, Change: +2.43, Percent Change: +15.63